The antiphospholipid syndrome (APS) is characterised by thrombotic or obstetric symptoms
associated with persistent antiphospholipid antibodies (aPL). Despite an increasing …

The antiphospholipid syndrome (APS) is characterized by a range of clinical features
(primarily thrombosis and/or obstetric-related), together with the presence of …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombotic and non-thrombotic macro-and microvascular manifestations and pregnancy …

The antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
occurrence of venous and arterial thromboses, often multiple, and obstetric-related adverse …

Persistently positive antiphospholipid antibodies (aPL) with thrombosis and/or pregnancy
morbidity are a characteristic of antiphospholipid syndrome (APS). Although many …

Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric
clinical manifestations developing in individuals with persistent antiphospholipid antibodies …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
thrombosis and/or obstetrical manifestations and the persistent presence, at least 12 weeks …

Antiphospholipid antibodies (aPLs) are associated with arterial and venous thrombosis,
recurrent pregnancy loss and thrombocytopenia. Although aPLs have not yet been …

Vascular thrombosis and pregnancy morbidity represent the clinical manifestations of
antiphospholipid syndrome (APS), which is serologically characterized by the persistent …

Antiphospholipid syndrome (APS) is an acquired autoimmune thrombophilia characterized
by thrombosis (venous and/or arterial or microvascular) and/or pregnancy loss or …